This company has been acquired
Forma Therapeutics Holdings Management
Management criteria checks 1/4
Key information
Frank Lee
Chief executive officer
US$9.3m
Total compensation
| CEO salary percentage | 6.7% |
| CEO tenure | 3.6yrs |
| CEO ownership | n/a |
| Management average tenure | 1.5yrs |
| Board average tenure | 3.3yrs |
Recent management updates
Recent updates
We're Keeping An Eye On Forma Therapeutics Holdings' (NASDAQ:FMTX) Cash Burn Rate
Aug 30
Forma Therapeutics GAAP EPS of -$1.10 misses by $0.11
Aug 05We're Hopeful That Forma Therapeutics Holdings (NASDAQ:FMTX) Will Use Its Cash Wisely
Mar 04We're Hopeful That Forma Therapeutics Holdings (NASDAQ:FMTX) Will Use Its Cash Wisely
Nov 20Here's Why We're Not Too Worried About Forma Therapeutics Holdings' (NASDAQ:FMTX) Cash Burn Situation
Aug 13We Think Forma Therapeutics Holdings (NASDAQ:FMTX) Needs To Drive Business Growth Carefully
Apr 18What Type Of Shareholders Own The Most Number of Forma Therapeutics Holdings, Inc. (NASDAQ:FMTX) Shares?
Jan 03Forma Therapeutics closes public offering priced at $45.25
Dec 16Forma Therapeutics prices equity offering at $45.25
Dec 11Forma Therapeutics' sickle cell treatment shows promising action at ASH presentation
Dec 08Forma Therapeutics EPS beats by $0.01
Nov 12Forma Therapeutics' sickle cell candidate an orphan drug in Europe
Nov 10CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2022 | n/a | n/a | -US$190m |
| Mar 31 2022 | n/a | n/a | -US$181m |
| Dec 31 2021 | US$9m | US$620k | -US$173m |
| Sep 30 2021 | n/a | n/a | -US$151m |
| Jun 30 2021 | n/a | n/a | -US$136m |
| Mar 31 2021 | n/a | n/a | -US$119m |
| Dec 31 2020 | US$6m | US$575k | -US$74m |
| Sep 30 2020 | n/a | n/a | -US$74m |
| Jun 30 2020 | n/a | n/a | -US$78m |
| Mar 31 2020 | n/a | n/a | -US$61m |
| Dec 31 2019 | US$4m | US$442k | -US$53m |
Compensation vs Market: Frank's total compensation ($USD9.31M) is above average for companies of similar size in the US market ($USD4.11M).
Compensation vs Earnings: Frank's compensation has increased whilst the company is unprofitable.
CEO
Frank Lee (54 yo)
3.6yrs
Tenure
US$9,307,807
Compensation
Mr. Frank D. Lee is Chair of the Board of Catamaran Bio, Inc. from April 2022. He serves as an Independent Director at Bolt Biotherapeutics, Inc. since November 2021. Mr. Lee is Chief Executive Officer of...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.6yrs | US$9.31m | no data | |
| Senior VP & CFO | 3.1yrs | US$3.03m | 0% $ 0 | |
| Senior VP & Chief Technology Officer | 1.3yrs | no data | 0% $ 0 | |
| Senior VP & Chief Scientific Officer | 2.5yrs | no data | 0.087% $ 829.8k | |
| Head of Investor Relations | no data | no data | no data | |
| Senior VP | 3.1yrs | no data | 0% $ 0 | |
| Vice President of Commercial Strategy & Marketing | less than a year | no data | no data | |
| Senior Vice President & Chief Human Resources Officer | less than a year | no data | no data | |
| Senior Vice President of Commercial | 1.8yrs | no data | 0% $ 0 | |
| Senior VP & Chief Patient Officer | less than a year | no data | no data | |
| Executive Vice President | less than a year | no data | no data | |
| Treasurer | no data | no data | no data |
1.5yrs
Average Tenure
57yo
Average Age
Experienced Management: FMTX's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.8yrs | US$9.31m | no data | |
| Independent Non-Executive Director | 2.1yrs | US$253.39k | 0% $ 0 | |
| Independent Non-Executive Chairman | 9.9yrs | US$294.14k | 0% $ 0 | |
| Independent Non-Executive Director | 8yrs | US$265.14k | 0% $ 0 | |
| Independent Non-Executive Director | 4.6yrs | US$253.64k | 0% $ 0 | |
| Independent Non-Executive Director | 2.8yrs | US$253.39k | 0% $ 0 | |
| Independent Director | less than a year | no data | no data | |
| Independent Non-Executive Director | 2.3yrs | US$255.02k | 0% $ 0 |
3.3yrs
Average Tenure
60yo
Average Age
Experienced Board: FMTX's board of directors are considered experienced (3.3 years average tenure).